21/11/2025
๐ก๐ฒ๐ ๐๐ฝ๐ฝ๐น๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป ๐ก๐ผ๐๐ฒ ๐ฅ๐ฒ๐น๐ฒ๐ฎ๐๐ฒ๐ฑ!
In collaboration with Everest Biolabs, we are excited to announce our latest application note:
โ๐๐ฅ๐ท๐ข๐ฏ๐ค๐ช๐ฏ๐จ ๐๐ญ๐ข๐ด๐ฎ๐ข ๐๐ฆ๐ณ๐ช๐ท๐ฆ๐ฅ ๐๐น๐ต๐ณ๐ข๐ค๐ฆ๐ญ๐ญ๐ถ๐ญ๐ข๐ณ ๐๐ฆ๐ด๐ช๐ค๐ญ๐ฆ ๐๐ฏ๐ข๐ญ๐บ๐ด๐ช๐ด ๐๐ฉ๐ณ๐ฐ๐ถ๐จ๐ฉ ๐๐ช๐จ๐ฉ-๐๐ถ๐ณ๐ช๐ต๐บ ๐๐ด๐ฐ๐ญ๐ข๐ต๐ช๐ฐ๐ฏ ๐ข๐ฏ๐ฅ ๐๐ข๐ณ๐ต๐ช๐ค๐ญ๐ฆ-๐๐ฑ๐ฆ๐ค๐ช๐ง๐ช๐ค ๐๐ถ๐ข๐ฏ๐ต๐ช๐ง๐ช๐ค๐ข๐ต๐ช๐ฐ๐ฏโ
One of the major challenges in (EV) research is that the majority of particles in plasma and serum are not EVs, but rather and protein aggregates, all overlapping in with vesicles.
This leads to:
ยท Inflated particle counts
ยท Masked EV-specific signals
ยท Misleading conclusions about EV abundance or biomarker levels
To overcome this, Everest Biolabs and Particle Metrix have partnered to establish a unified EV analysis workflow, combining:
ยท High-purity SEC isolation using Apex SEC columns
ยท Accurate, particle-specific quantification via advanced Nanoparticle Tracking Analysis (NTA)
The result: higher purity, greater reproducibility, and more reliable quantitative EV analysis.
๐ https://www.particle-metrix.com/blogs/application-notes/advancing-plasma-derived-extracellular-vesicle-analysis-through-high-purity-isolation-and-particle-specific-quantification
๐ ๐ฒ๐ฒ๐ ๐จ๐ ๐ถ๐ป ๐ฃ๐ฒ๐ฟ๐๐ผ๐ป!
From November 20โ23, 2025, Everest Biolabs and Particle Metrix will be attending the American Association of Extracellular Vesicles ( ) Annual Meeting in Salt Lake City.
We invite you to stop by our booths to discuss the new , dive deeper into the workflow, and explore how this approach can support your specific research needs.
Come by and say hello - we look forward to seeing you in Salt Lake City!